171 Results for "

Side effects

" in MedChemExpress (MCE) Product Catalog:
Products (171)

171 Results for "Side effects" in MCE Product Catalog:

Cat. No.: HY-W050088
CAS No.: 55453-87-7
Synonyms: HP 549
Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases .
loading...
    loading...
Cat. No.: HY-123352
CAS No.: 669073-68-1
Purity:  98.59%
Synonyms: (+)-ZK 216348
ZK 216348 ((+)-ZK 216348) is a nonsteroidal selective glucocorticoid receptor agonist with an IC50 of 20.3 nM. ZK 216348 also binds to Progesterone and mineralocorticoid receptors with IC50s of 20.4 nM and 79.9 nM, respectively. ZK 216348 has antiinflammatory activity similar to Prednisolone and induces less transactivation-mediated side effects .
loading...
    loading...
Cat. No.: HY-B2112
CAS No.: 90-22-2
Target:  

mAChR

Research Areas:  

Neurological Disease

Valethamate bromide is an ester, serving as an effective rapidly acting anticholinergic antispasmodic and muscle relaxant. Valethamate bromide accelerates labor by improving cervical dilation. Valethamate bromide can significantly shorten the labor process and have fewer side effects .
loading...
    loading...
Cat. No.: HY-107345
CAS No.: 90101-16-9
Synonyms: Ombolan
Research Areas:  

Inflammation/Immunology

Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse .
loading...
    loading...
Cat. No.: HY-155113
CAS No.: 3031078-90-4
Target:  

PROTACs HSP

Research Areas:  

Cancer

PROTAC Hsp90α degrader 1 is a selective PROTAC Hsp90α degrader with a DC50 of 0.295 μM. PROTAC Hsp90α degrader 1 exhibits antitumor activity with low toxic side effects. PROTAC Hsp90α degrader 1 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-145736A
CAS No.: 2246364-63-4
Research Areas:  

Cancer

β-Glucuronide-dPBD-PEG5-NH2 TFA is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD.β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2 TFA, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 TFA can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 TFA has antitumor activity .
loading...
    loading...
Cat. No.: HY-16103
CAS No.: 30392-41-7
Synonyms: Win 32784; Bitolterol methanesulfonate; S-1540 mesylate
Target:  

Drug Derivative

Research Areas:  

Infection

Bitolterol mesylate (WIN 37284) is a diester-type agonist amine bronchodilator without significant cardiac side effects .
loading...
    loading...
Cat. No.: HY-115709
CAS No.: 30688-66-5
Target:  

Drug Derivative

Research Areas:  

Cancer

4,6-O-Benzylidene-D-glucose is a benzaldehyde derivative. 4,6-O-Benzylidene-D-glucose exerts anticancer effects without causing side effects .
loading...
    loading...
Cat. No.: HY-13556
CAS No.: 182133-25-1
Synonyms: LY353381; SERM III
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Cancer

Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator with a fixed ring structure similar to raloxifene. Arzoxifene has minimal side effects with powerful antiestrogenic effects on breast cancer and endometrium, with equally strong favorable estrogenic effects on bone and lipid profile .
loading...
    loading...
Cat. No.: HY-P99436
CAS No.: 1370261-50-9
Synonyms: ABR-214936
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
loading...
    loading...
Cat. No.: HY-N1965
CAS No.: 490-67-5
Gaultherin is an orally active non-steroidal anti-inflammatory agent. Gaultherin selectively inhibits NF-κB, MAPK, COX-2 (IC50 = 0.35 mg/mL), LOX (IC50 = 0.56 mg/mL) and HYAL (IC50 = 28.58 μg/mL) to exert anti-inflammatory, antipyretic and analgesic effects. Gaultherin exhibits modest direct antioxidant capacity, greater in cell-based models. Gaultherin does not affect COX-1 so that avoids the common gastrointestinal side effects of Aspirin (HY-14654) .
loading...
    loading...
Cat. No.: HY-145736
CAS No.: 2246363-68-6
Research Areas:  

Cancer

β-Glucuronide-dPBD-PEG5-NH2 is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD. β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 has antitumor activity .
loading...
    loading...
Cat. No.: HY-136281
CAS No.: 135135-87-4
Purity:  98.82%
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

DuP 734 is a sigma receptor antagonist. DuP 734 is a selective and potent sigma and 5-HT2 receptor ligand with weak affinity for D2 receptors. DuP 734 may have antipsychotic activity without the liability of motor side effects typical of neuroleptics .
loading...
    loading...
Cat. No.: HY-179511
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α-Glucosidase-IN-104 (Compound 9s) is an efficient inhibitor of α-glucosidase with an IC50 of 24.32 μM. α-Glucosidase-IN-104 has a weak inhibitory effect on α-amylase and avoids gastrointestinal side effects. α-Glucosidase-IN-104 can be used for research on type 2 diabetes .
loading...
    loading...
Cat. No.: HY-118249
CAS No.: 1168138-37-1
Target:  

PPAR

Research Areas:  

Neurological Disease

GSK 1997132B is a benzimidazole-based PPARγ partial agonist that can cross the blood-brain barrier with a pEC50 value of 8.0. GSK 1997132B has no significant effect on PPARα/δ. GSK 1997132B improves the problem of high blood clearance rate of earlier compounds, avoiding side effects such as weight gain and edema. GSK 1997132B can be used for research on Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-165527
CAS No.: 200398-40-9
Research Areas:  

Neurological Disease

S18327 is a multi-target antipsychotic agent. S18327 exerts its efficacy by acting on multiple neurotransmitter systems in the brain, and it has antagonistic effects on dopamine receptors (particularly the D2 receptor) and 5-hydroxytryptamine 2A receptors (5-HT2A receptor). S18327 can counteract excessive dopamine activity and hypo-function of glutamate. S18327 exhibits a multi-parameter pharmacological profile that is highly similar to that of Clozapine (HY-14539). S18327 can produce the same discriminative stimulus as Clozapine, improve cognitive filtering deficits associated with schizophrenia, and display anxiolytic properties. S18327 has relatively weak affinity for histaminergic receptors and muscarinic receptors, which avoids the side effects of Clozapine .
loading...
    loading...
Cat. No.: HY-106605
CAS No.: 61325-80-2
Synonyms: LY 120363
Research Areas:  

Neurological Disease

Flumezapine (LY 120363) is a potent and balanced antagonist of the dopamine D2 receptor and the 5-hydroxytryptamine receptor (5-HT receptor). Flumezapine does not alter the increase in serum cortisol caused by κ-opioid receptor agonists. Flumezapine inhibits the conditioned avoidance response in rats and has a low risk of extrapyramidal side effects. Flumezapine can be used in antipsychotic research .
loading...
    loading...
Cat. No.: HY-122281
CAS No.: 194358-72-0
Target:  

Cannabinoid Receptor

Research Areas:  

Others

JTE 7-31 selectively acts on peripheral cannabinoid receptors, minimizing central nervous system side effects. They exhibit potent immunomodulatory, anti-inflammatory and anti-allergic properties, as well as inhibitory effects on nephritis .
loading...
    loading...
Cat. No.: HY-U00045
CAS No.: 98123-83-2
Synonyms: BRL-38705
Target:  

Parasite

Research Areas:  

Others

Epsiprantel (BRL-38705) is a compound with anti-Echinococcus activity that can cause the death of protoscolex, larvae and adults in vitro, and is more effective against mature worms than larvae in vivo, with no side effects.
loading...
    loading...
Cat. No.: HY-P10394
CAS No.: 2376306-14-6
DP32 is a bifunctional compound that contains an opioid receptor (MOP) agonist and a neuropeptide FF receptor (NPFFR) antagonist. DP32 can be used in analgesia-related research .
loading...
    loading...